 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
20 News |  |
- | latanoprost punctal plug delivery system (L-PPDS) / Mati Therapeutics
Journal: High Performance All-Polymer Photodetectors via Thick Photoactive Layer Strategy. (Pubmed Central) - Mar 26, 2019
More importantly, the resultant all-PPDs exhibited a high working frequency over 10 kHz associated with a large linear dynamic range. These findings demonstrate the great potential for practical applications of the all-PPDs developed in this work.
- |||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial completion: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Jan 10, 2017
P2, N=86, Completed, Sponsor: Mati Therapeutics Inc.
These findings demonstrate the great potential for practical applications of the all-PPDs developed in this work. Active, not recruiting --> Completed
- ||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment closed, Trial primary completion date: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 30, 2016
P2, N=86, Active, not recruiting, Sponsor: Mati Therapeutics Inc.
Active, not recruiting --> Completed Completed --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Dec 2016
- |||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial completion, Enrollment change: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 23, 2016
P2, N=86, Completed, Sponsor: Mati Therapeutics Inc.
Completed --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Dec 2016 Recruiting --> Completed | N=120 --> 86
- || latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial primary completion date: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Feb 11, 2016
P2, N=120, Recruiting, Sponsor: Mati Therapeutics Inc.
Recruiting --> Completed | N=120 --> 86 Trial primary completion date: Dec 2015 --> Jun 2016
- ||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment change: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Aug 26, 2015
P2, N=120, Recruiting, Sponsor: Mati Therapeutics Inc.
Trial primary completion date: Dec 2015 --> Jun 2016 N=90 --> 120
- || latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial primary completion date: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Jun 11, 2015
P2, N=90, Recruiting, Sponsor: Mati Therapeutics Inc.
N=90 --> 120 Trial primary completion date: Jun 2015 --> Sep 2015
- || latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial primary completion date: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Apr 14, 2015
P2, N=90, Recruiting, Sponsor: Mati Therapeutics Inc.
Trial primary completion date: Jun 2015 --> Sep 2015 Trial primary completion date: Dec 2014 --> Jun 2015
- ||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment change: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 5, 2014
P2, N=90, Recruiting, Sponsor: Mati Therapeutics Inc.
Trial primary completion date: Dec 2014 --> Jun 2015 N=120 --> 90
- || latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial primary completion date: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Jun 3, 2014
P2, N=120, Recruiting, Sponsor: Mati Therapeutics Inc.
N=120 --> 90 Trial primary completion date: Jun 2014 --> Dec 2014
- ||||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
New P2 trial: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Dec 16, 2013
P2, N=120, Recruiting, Sponsor: Mati Therapeutics Inc.
- ||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment change: A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 15, 2013
P2, N=121, Completed, Sponsor: Mati Therapeutics Inc.
Trial primary completion date: Jun 2014 --> Dec 2014 N=60 --> 121
- latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment change: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 15, 2013
P2, N=0, Withdrawn, Sponsor: Mati Therapeutics Inc.
N=60 --> 121 N=40 --> 0
- ||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Enrollment change: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Oct 2, 2012
P2, N=57, Completed, Sponsor: Mati Therapeutics Inc.
N=40 --> 0 N=45 --> 57
- |||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial completion: A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Oct 2, 2012
P2, N=77, Completed, Sponsor: Mati Therapeutics Inc.
N=45 --> 57 Active, not recruiting --> Completed
- |||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial completion: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Oct 2, 2012
P2, N=57, Completed, Sponsor: Mati Therapeutics Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
New P2 trial: A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Nov 27, 2011
P2, N=77, Completed, Sponsor: Mati Therapeutics Inc.
- ||||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
New P2 trial: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Nov 27, 2011
P2, N=57, Completed, Sponsor: Mati Therapeutics Inc.
- |||| latanoprost punctal plug delivery system (L-PPDS) / Mati Therap
Trial completion: A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (clinicaltrials.gov) - Sep 14, 2011
P2, N=121, Completed, Sponsor: Mati Therapeutics Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed